Patents by Inventor James Tobin

James Tobin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to human interleukin-11 receptor
    Patent number: 7094402
    Abstract: Polynucleotides encoding the human IL-11 receptor and fragments thereof are disclosed. IL-11 receptor proteins, methods for their production, antibodies to human IL-11 receptor, inhibitors of binding of human IL-11 and its receptor and methods for identification of their receptor are also disclosed.
    Type: Grant
    Filed: August 7, 2001
    Date of Patent: August 22, 2006
    Assignee: Genetics Institute, LLC
    Inventor: James Tobin
  • Combination therapy for diabetes, obesity and cardiovascular diseases using GDF-8 inhibitors
    Publication number: 20060034831
    Abstract: A method of treating obesity, cardiovascular diseases, and disorders of insulin metabolism in a subject, comprising administering to the subject a therapeutically effective amount of a GDF-8 inhibitor, and a therapeutically effective amount of at least one other therapeutic agent which treats the targeted syndrome.
    Type: Application
    Filed: August 11, 2005
    Publication date: February 16, 2006
    Inventor: James Tobin
  • EMBOLIC COMPOSITIONS
    Publication number: 20050095428
    Abstract: Embolic compositions and methods of delivering the compositions are disclosed. In some embodiments, the embolic compositions include a shape memory material.
    Type: Application
    Filed: March 2, 2004
    Publication date: May 5, 2005
    Inventors: Paul Dicarlo, Robert Rioux, James Tobin, Barbara Bell, Thomas Casey, William Shaw
  • DNA encoding human interleukin-11 receptor
    Patent number: 6528281
    Abstract: Polynucleotides encoding the human IL-11 receptor and fragments thereof are disclosed. IL-11 receptor proteins, methods for their production, inhibitors of binding of human IL-11 and its receptor and methods for their identification are also disclosed.
    Type: Grant
    Filed: June 14, 1996
    Date of Patent: March 4, 2003
    Assignee: Genetics Institute, Inc.
    Inventor: James Tobin
  • Human interleukin-11 receptor
    Publication number: 20020082233
    Abstract: Polynucleotides encoding the human IL-11 receptor and fragments thereof are disclosed. IL-11 receptor proteins, methods for their production, inhibitors of binding of human IL-11 and its receptor and methods for their identification are also disclosed.
    Type: Application
    Filed: August 7, 2001
    Publication date: June 27, 2002
    Applicant: Genetics Institute
    Inventor: James Tobin
  • Human interleukin-11 receptor
    Patent number: 6350855
    Abstract: Polynucleotides encoding the human IL-11 receptor and fragments thereof are disclosed. IL-11 receptor proteins, methods for their production, inhibitors of binding of human IL-11 and its receptor and methods for their identification are also disclosed.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: February 26, 2002
    Assignee: Genetics Institute, Inc.
    Inventor: James Tobin
  • Methods comprising the use of human interleukin-11 receptor proteins
    Patent number: 6274547
    Abstract: Polynucleotides encoding the human IL-11 receptor and fragments thereof are disclosed. IL-11 receptor proteins, methods for their production, inhibitors of binding of human IL-11 and its receptor and methods for their identification are also disclosed.
    Type: Grant
    Filed: September 10, 1998
    Date of Patent: August 14, 2001
    Assignee: Genetics Institute, Inc.
    Inventor: James Tobin
  • Production of pharmaceutical formulations for treatment of edema and venous disorders
    Patent number: 6077534
    Abstract: The invention relates to a medicament containing a standardized dry extract of horse chestnut seeds which is active against various types of edema and diseases of the venous circulatory system and to a process for manufacturing this medicament. The dry seed extract is processed to the form of pellets which can be coated to obtain sustained release of the agent. In this way satisfying therapeutical blood levels of the triterpene glycosides as agent are achieved. The finished medicament according to the invention can best be provided as hard gelatin capsule or matrix tablet containing the extract pellets.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: June 20, 2000
    Assignee: Klinge Pharma GmbH
    Inventors: James Tobin, Gerd Ulfert Heese
  • Dual spring actuator for keyboard switch assembly
    Patent number: 4117292
    Abstract: An economical yet versatile dual spring actuator switch assembly providing an excellent tactile impression includes a planar switch closure assembly having domed protrusions extending from a surface thereof to provide switch closure when depressed and a switch actuator assembly.
    Type: Grant
    Filed: June 10, 1977
    Date of Patent: September 26, 1978
    Assignee: Telaris Telecommunications, Inc.
    Inventors: James Christopher Hayes, William James Tobin